Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.
- DOI
- 10.1038/s43018-025-01113-y
- Published
- 2026 Feb
- Container
- Nature cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s43018-025-01113-y,
title = {Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.},
author = {Kendra KL and Bellasea SL and Eroglu Z and Hu-Lieskovan S and Campbell KM and Carson WE 3rd and Wada DA and Plaza JA and In GK and Ikeguchi A and Hyngstrom J and Brohl AS and Chmielowski B and Khushalani NI and Markowitz J and Monroe M and Contreras CM and Bowles T and Norman K and Medina E and Gonzalez CR and Baselga-Carretero I and Garcilazo IP and Vega-Crespo A and Chen JM and Deen NNA and Patel SP and Grossmann KF and Sondak VK and Sharon E and Moon J and Wu MC and Ribas A},
year = {2026},
journal = {Nature cancer},
doi = {10.1038/s43018-025-01113-y},
url = {https://doi.org/10.1038/s43018-025-01113-y}
}RIS
TY - JOUR TI - Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial. AU - Kendra KL AU - Bellasea SL AU - Eroglu Z AU - Hu-Lieskovan S AU - Campbell KM AU - Carson WE 3rd AU - Wada DA AU - Plaza JA AU - In GK AU - Ikeguchi A AU - Hyngstrom J AU - Brohl AS AU - Chmielowski B AU - Khushalani NI AU - Markowitz J AU - Monroe M AU - Contreras CM AU - Bowles T AU - Norman K AU - Medina E AU - Gonzalez CR AU - Baselga-Carretero I AU - Garcilazo IP AU - Vega-Crespo A AU - Chen JM AU - Deen NNA AU - Patel SP AU - Grossmann KF AU - Sondak VK AU - Sharon E AU - Moon J AU - Wu MC AU - Ribas A PY - 2026 JO - Nature cancer DO - 10.1038/s43018-025-01113-y UR - https://doi.org/10.1038/s43018-025-01113-y ER -
APA
KL, K., SL, B., Z, E., S, H., KM, C., 3rd, C. W., DA, W., JA, P., GK, I., A, I., J, H., AS, B., B, C., NI, K., J, M., M, M., CM, C., T, B., K, N., E, M., CR, G., I, B., IP, G., A, V., JM, C., NNA, D., SP, P., KF, G., VK, S., E, S., J, M., MC, W., & A, R. (2026). Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.. Nature cancer. https://doi.org/10.1038/s43018-025-01113-y
Source records
- pubmed · retrieved 2026-09-26T16:16:25.581Z
- europe-pmc · retrieved 2026-09-26T16:16:25.595Z